“…In fact, the active metabolite of WR-2721 is the WR-1065 free sulfhydryl form, which is able to interact with the nuclear material. Yuhas and coworkers have shown that WR-2721 is an anticancer molecule [6]; this drug can protect solid tumors and normal tissues, in a differential manner, in radiotherapy and chemotherapy and can also reduce the nephrotoxicity of cisplatin without antitumoral activity alteration [7-91. We have shown previously by spectrophotometric and dielectric measure- ments that a strong electrostatic interaction occurs between the cationic forms of these aminothiols and the phosphate sites of DNA [10-121. On the other hand, we have studied, using quantum computations, the conformations and electrostatic properties of cysteamine, methylated cysteamine, WR-2578 in free sulfhydryl form, and WR-1065 [5,[12][13][14].…”